Browse By Person: Adams, Mark
|Up a level|
Group by: Item Type | Date
Number of items: 9.
Adams, Mark N., Ashton, Nicholas W., Paquet, Nicolas, O'Byrne, Kenneth J., & Richard, Derek J. (2014) Mechanisms of cisplatin resistance: DNA repair and cellular implications. In Morais, Christudas (Ed.) Advances in Drug Resistance Research. Nova Science Publishers, New York, pp. 1-37.
Jekimovs, Christian, Bolderson, Emma, Suraweera, Amila, Adams, Mark, O'Byrne, Kenneth J., & Richard, Derek J. (2014) Chemotherapeutic compounds targeting the DNA double-strand break repair pathways : the good, the bad, and the promising. Frontiers in Oncology, 4(86).
Dong, Ying, Harrington, Brittney S., Adams, Mark N., Wortmann, Andreas, Stephenson, Sally-Anne, Lisle, Jessica E., et al. (2014) Activation of membrane-bound proteins and receptor systems: A link between tissue kallikrein and the KLK-related peptidases. Biological Chemistry, 395(9), pp. 977-990.
Adams, Mark, Ramachandran, Rithwik, Yau, Mei-Kwan, Suen, Jacky, Fairlie, David, Hollenberg, Morley, et al. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacology and Therapeutics, 130(3), pp. 248-282.
Adams, Mark, Christensen, Melinda, He, Yaowu, Waterhouse, Nigel, & Hooper, John (2011) The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2. PLoS ONE, 6(11), pp. 1-14.
He, Yaowu, Wortmann, Andreas, Burke, Leslie, Reid, Janet, Adams, Mark, Abdul-Jabbar, Ibtissam, et al. (2010) Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKC? Journal of Biological Chemistry, 285(34), pp. 26162-26173.
Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A., et al. (2008) Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Biological Chemistry, 389(6), pp. 653-668.
Burgess, Joshua T., Croft, Laura V., Wallace, Nathan C., Stephenson, Sally-Anne, Adams, Mark N., Ashton, Nicholas W., et al. (2014) DNA repair pathways and their therapeutic potential in lung cancer. Lung Cancer Management, 3(2), pp. 159-173.
Adams, Mark N. (2012) In vitro and in vivo studies on protease-activated receptor-2. PhD thesis, Queensland University of Technology.